Vincerx Pharma IncNASDAQ:VINCNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6800
- TODAY'S CHANGE (%)0.0240 (3.6585%)
- Bid / Lots0.6503/ 13
- Ask / Lots0.7000/ 100
- Open / Previous Close0.6656 / 0.6560
- Day Range
- 52 Week Range
- Volume111,814
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VINC |
|---|---|---|
| 09:32 ET | 1140 | 0.6656 |
| 09:52 ET | 3000 | 0.666649 |
| 09:54 ET | 155 | 0.66 |
| 09:59 ET | 300 | 0.6699 |
| 10:03 ET | 835 | 0.67 |
| 10:14 ET | 3781 | 0.695 |
| 10:15 ET | 479 | 0.695 |
| 10:19 ET | 5797 | 0.6892 |
| 10:26 ET | 480 | 0.6844 |
| 10:28 ET | 6226 | 0.68 |
| 10:30 ET | 173 | 0.6706 |
| 10:32 ET | 564 | 0.67 |
| 10:39 ET | 100 | 0.6706 |
| 10:44 ET | 100 | 0.6706 |
| 10:46 ET | 200 | 0.67 |
| 10:50 ET | 540 | 0.6667 |
| 10:57 ET | 150 | 0.6665 |
| 11:11 ET | 3000 | 0.6704 |
| 11:13 ET | 12836 | 0.68 |
| 11:15 ET | 4511 | 0.6799 |
| 11:27 ET | 121 | 0.6716 |
| 11:33 ET | 792 | 0.6749 |
| 11:47 ET | 500 | 0.6749 |
| 11:54 ET | 200 | 0.6774 |
| 12:00 ET | 1500 | 0.677399 |
| 12:20 ET | 1577 | 0.69 |
| 12:25 ET | 1901 | 0.67962 |
| 12:43 ET | 800 | 0.679 |
| 01:12 ET | 3243 | 0.6791 |
| 01:21 ET | 100 | 0.6866 |
| 01:28 ET | 500 | 0.68336 |
| 01:30 ET | 100 | 0.683 |
| 01:35 ET | 100 | 0.6796 |
| 01:53 ET | 100 | 0.682644 |
| 01:57 ET | 206 | 0.6821 |
| 03:07 ET | 750 | 0.6763 |
| 03:25 ET | 500 | 0.6761 |
| 03:32 ET | 630 | 0.6761 |
| 03:41 ET | 500 | 0.676201 |
| 03:48 ET | 762 | 0.683 |
| 03:50 ET | 10610 | 0.6782 |
| 03:54 ET | 600 | 0.68 |
| 03:57 ET | 18097 | 0.68 |
| 03:59 ET | 12327 | 0.68 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vincerx Pharma Inc | 19.5M | -0.4x | --- |
Ibio Inc | 19.1M | -0.2x | --- |
Eom Pharmaceutical Holdings Inc | 19.1M | -2.5x | --- |
Goldenwell Biotech Inc | 19.8M | -168.1x | --- |
Viracta Therapeutics Inc | 19.1M | -0.4x | --- |
Gain Therapeutics Inc | 18.8M | -0.7x | --- |
Company Information
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9 inhibitor). VIP943 is a potential anti-CD123 ADC created with its VersAptx Platform. It consists of an anti-CD123 antibody, a novel legumain-cleavable linker, and a KSPi payload enhanced with its CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.
Contact Information
- Headquarters
- 260 Sheridan Avenue, Suite 400PALO ALTO, CA, United States 94306
- Phone
- 650-800-6676
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Ahmed Hamdy
- President, Chief Operating Officer, Director
- Raquel Izumi
- Chief Financial Officer
- Alexander Seelenberger
- General Counsel, Chief Legal Officer
- Tom Thomas
- Independent Director
- Laura Bushnell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.19 |
EPS | $-1.79 |
Book Value | $0.52 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
